Manulife (Manufacturers Life Insurance)
AST

Manulife (Manufacturers Life Insurance)’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio AST Stock Details AST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-4
Closed – – 4355
2018
Q2 		$0 Hold
4
– – ﹤0.01% 4491
2018
Q1 		$0 Sell
4
-5,572
-100% -$11.6K ﹤0.01% 4473
2017
Q4 		$13K Buy
+5,576
New +$14.1K ﹤0.01% 3923
2017
Q3 		– Sell
-166
Closed -$1K – 4508
2017
Q2 		$1K Sell
166
-16
-9% -$53 ﹤0.01% 4340
2017
Q1 		$1K Hold
182
– – ﹤0.01% 4175
2016
Q4 		$1K Hold
182
– – ﹤0.01% 4323
2016
Q3 		$1K Hold
182
– – ﹤0.01% 4269
2016
Q2 		$0 Sell
182
-2,284
-93% -$8.26K ﹤0.01% 4500
2016
Q1 		$11K Buy
2,466
+2,284
+1,255% +$8.84K ﹤0.01% 3625
2015
Q4 		$1 Hold
182
– – ﹤0.01% 3993
2015
Q3 		$1 Hold
182
– – ﹤0.01% 4037
2015
Q2 		$1 Hold
182
– – ﹤0.01% 4011
2015
Q1 		$1 Hold
182
– – ﹤0.01% 3975
2014
Q4 		$1 Buy
+182
New +$733 ﹤0.01% 3923

Other funds holding AST

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s AST Position: Q3 2018 in Review

Manulife (Manufacturers Life Insurance) sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q3 2018, closing a stake of 4 shares.

Manulife (Manufacturers Life Insurance) first reported a position in AST in Q4 2014 and held it in 14 quarters. The position peaked at $13K in Q4 2017. 54 funds tracked by Wall St. Rank hold AST as of Q3 2018.

  • Manulife (Manufacturers Life Insurance) reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q3 2018 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 4 Asterias Biotherapeutics Inc. Series A shares in Q3 2018.
  • Manulife (Manufacturers Life Insurance) first reported a position in Asterias Biotherapeutics Inc. Series A in Q4 2014 and held it in 14 quarters.
  • Manulife (Manufacturers Life Insurance)'s Asterias Biotherapeutics Inc. Series A position peaked at $13K in Q4 2017.
  • 54 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q3 2018.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2018, filed 14 Nov 2018.